
GC65248
Etripamil
Also known as methyl 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-methylamino]ethyl]benzoate
Etripamil (MSP-2017) is a short-acting L-type calcium-channel antagonist, can be used for the research of Paroxysmal Supraventricular Tachycardia (PSVT)
ChemicalCAS1593673-23-4MW452.59FormulaC27H36N2O4
- CAS number
- 1593673-23-4
- Molecular weight
- 452.59
- Formula
- C27H36N2O4
- Solubility
- Ethanol : 120 mg/mL (265·14 mM; Need ultrasonic)
- InChIKey
- VAZNEHLGJGSQEL-MHZLTWQESA-N
- Catalogue number
- GC65248
- Brand
- GLPBIO
Computed properties PubChem CID 91824132 · XLogP 3.7 · TPSA 71.8 Ų · H-bond donors 0
- XLogP
- 3.7
- TPSA
- 71.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Rotatable bonds
- 13
- Heavy atoms
- 33
SMILES CC(C)[C@](CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC
Computed descriptors from PubChem (CID 91824132), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il